TTAX01
- Generic Name
- TTAX01
- Drug Type
- Biotech
- Background
TTAX01 is a cryopreserved human umbilical cord product being developed by TissueTech.
Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II)
Phase 3
Completed
- Conditions
- Non-healing Diabetic Foot UlcerDiabetic Foot InfectionNon-healing Wound
- Interventions
- Other: Standard care
- First Posted Date
- 2020-06-29
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- BioTissue Holdings, Inc
- Target Recruit Count
- 106
- Registration Number
- NCT04450693
- Locations
- 🇺🇸
LakeView Clinical Research, Guntersville, Alabama, United States
🇺🇸Banner University Medical Center Tucson, Tucson, Arizona, United States
🇺🇸Clemente Clinical Research, Los Angeles, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath